| Neural substrates of overgeneralized conditioned fear in PTSD AN Kaczkurkin, PC Burton, SM Chazin, AB Manbeck, T Espensen-Sturges, ... American journal of psychiatry 174 (2), 125-134, 2017 | 292 | 2017 |
| The novel vasopressin receptor (V1aR) antagonist SRX246 reduces anxiety in an experimental model in humans: a randomized proof-of-concept study TR Lago, MJ Brownstein, E Page, E Beydler, A Manbeck, A Beale, ... Psychopharmacology 238 (9), 2393-2403, 2021 | 27 | 2021 |
| Reversing threat contingencies enhances generalization of conditioned fear AB Manbeck, SE Cooper, S Lissek Learning and Motivation 80, 101843, 2022 | 4 | 2022 |
| Detecting the hot hand in amateur bowlers MA Stellmack, AJ Byrne, S Sheft, NA Salovich, AB Manbeck International Journal of Sport and Exercise Psychology 22 (9), 2342-2358, 2024 | 2 | 2024 |
| Intolerance of uncertainty as a predictor of anxiety severity and trajectory during the COVID-19 pandemic R Breaux, K Naragon-Gainey, BA Katz, LR Starr, JG Stewart, ... Journal of anxiety disorders 106, 102910, 2024 | 2 | 2024 |
| Effects of SRX246, a vasopressin 1a receptor (V1a) antagonist, on an experimental model of phasic and sustained threat in humans T Lago, M Brownstein, E Beydler, A Manbeck, A Beale, N Simon, M Ernst, ... Biological Psychiatry 87 (9), S167-S168, 2020 | 2 | 2020 |
| Periaqueductal gray matter and medial prefrontal cortex reflect negative prediction errors during differential conditioning AX Gorka, RT Philips, S Torrisi, A Manbeck, M Goodwin, M Ernst, ... Social Cognitive and Affective Neuroscience 18 (1), nsad025, 2023 | | 2023 |
| Impaired Attenuation of Maladaptive Generalized Avoidance by Safety-Related Brain Activity in Clinical Anxiety H Berg, SE Cooper, C Hunt, R Webler, A Manbeck, A Hammell, PC Burton, ... Biological Psychiatry 89 (9), S173, 2021 | | 2021 |
| Proclivities Toward Behavioral Approach Associated With Reduced Maladaptive Avoidance: An fMRI Study L Hagen, A Rust, H Berg, SE Cooper, C Hunt, R Webler, A Manbeck, ... Biological Psychiatry 89 (9), S244, 2021 | | 2021 |
| Effects of SRX246, a Vasopressin Receptor (V1a) Antagonist, on an Experimental Model of Phasic and Sustained Threat in Humans T Lago, M Brownstein, E Beydler, A Manbeck, A Beale, N Simon, C Grillon, ... NEUROPSYCHOPHARMACOLOGY 44 (SUPPL 1), 394-394, 2019 | | 2019 |
| OVERGENERALIZATION OF CONDITIONED FEAR IS A PATHOGENIC MARKER OF PTSD AFTER CONTROLLING FOR EFFECTS OF DYSPHORIA A Manbeck, SE Cooper, B Van Meurs, SR Sponheim, S Lissek PSYCHOPHYSIOLOGY 53, S67-S67, 2016 | | 2016 |
